JP2006501166A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006501166A5 JP2006501166A5 JP2004510825A JP2004510825A JP2006501166A5 JP 2006501166 A5 JP2006501166 A5 JP 2006501166A5 JP 2004510825 A JP2004510825 A JP 2004510825A JP 2004510825 A JP2004510825 A JP 2004510825A JP 2006501166 A5 JP2006501166 A5 JP 2006501166A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- heterologous
- immunogenic
- immunogenic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0213364A GB0213364D0 (en) | 2002-06-11 | 2002-06-11 | Vaccine |
| GB0221689A GB0221689D0 (en) | 2002-09-18 | 2002-09-18 | Vaccine |
| PCT/EP2003/006095 WO2003103706A2 (en) | 2002-06-11 | 2003-06-06 | Immunogenic compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006501166A JP2006501166A (ja) | 2006-01-12 |
| JP2006501166A5 true JP2006501166A5 (enExample) | 2006-06-22 |
Family
ID=29738081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004510825A Pending JP2006501166A (ja) | 2002-06-11 | 2003-06-06 | 異種前立腺タンパク質ｐ５０１ｓを含む免疫原性組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060140965A1 (enExample) |
| EP (1) | EP1511513A2 (enExample) |
| JP (1) | JP2006501166A (enExample) |
| AU (1) | AU2003250828A1 (enExample) |
| CA (1) | CA2487907A1 (enExample) |
| WO (1) | WO2003103706A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2570563A1 (en) * | 2004-06-15 | 2006-09-28 | Centocor, Inc. | Method for screening agents against human prostate disease |
| JP2008546788A (ja) * | 2005-06-21 | 2008-12-25 | サイト パルス サイエンシズ、インコーポレイテッド | 前立腺癌に対するワクチンに関する方法及び組成物 |
| CN102186499B (zh) * | 2008-08-20 | 2015-05-20 | Ibc医药公司 | 用于癌症治疗的对接和锁定(dnl)疫苗 |
| EP3592800A4 (en) | 2017-03-10 | 2021-01-06 | Bolt Threads, Inc. | COMPOSITIONS AND METHODS OF PRODUCING HIGHLY SECRETED YIELD OF RECOMBINANT PROTEIN |
| KR102486713B1 (ko) | 2017-03-10 | 2023-01-10 | 볼트 쓰레즈, 인크. | 재조합 단백질을 고분비 수율로 생산하기 위한 조성물 및 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2286477A1 (en) * | 1997-04-11 | 1998-10-22 | Dendreon Corporation | Composition and method for inducing an immune response against tumour-related antigens |
| JP2002506618A (ja) * | 1998-03-20 | 2002-03-05 | ジェンザイム・コーポレーション | 腫瘍自己抗原に対する免疫誘導 |
| HUP0203035A3 (en) * | 1998-07-14 | 2007-12-28 | Corixa Corp | Compositions and methods for therapy and diagnosis of prostate cancer |
| WO2001025273A2 (en) * | 1999-10-04 | 2001-04-12 | Corixa Corporation | Compositions and methods for wt1 specific immunotherapy |
| US20020009455A1 (en) * | 2000-04-27 | 2002-01-24 | Ted Lau | DNA encoding a novel PROST 03 polypeptide |
-
2003
- 2003-06-06 WO PCT/EP2003/006095 patent/WO2003103706A2/en not_active Ceased
- 2003-06-06 CA CA002487907A patent/CA2487907A1/en not_active Abandoned
- 2003-06-06 US US10/517,552 patent/US20060140965A1/en not_active Abandoned
- 2003-06-06 JP JP2004510825A patent/JP2006501166A/ja active Pending
- 2003-06-06 AU AU2003250828A patent/AU2003250828A1/en not_active Abandoned
- 2003-06-06 EP EP03757055A patent/EP1511513A2/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5479918B2 (ja) | 子宮頸癌の治療のための組成物および方法 | |
| EP1053325B1 (en) | Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination | |
| EP1108035B1 (en) | Treatment of cervical cancer | |
| WO2017191264A1 (en) | Nucleic acid molecules and uses thereof | |
| US20190343942A1 (en) | Rna encoding a tumor antigen | |
| ES2365077T3 (es) | Péptido antígeno anticáncer derivado de sparc y composición farmacéutica que comprende el mismo. | |
| RU2013152648A (ru) | Аденовирус обезьян и гибридные аденовирусные векторы | |
| JP2013537422A (ja) | ヒトパピローマウイルス変形体及び免疫増強剤を含む子宮頸癌の予防または治療用組成物 | |
| JP2008056679A5 (enExample) | ||
| JP2020528743A5 (enExample) | ||
| JP2003511010A (ja) | ヒト細胞中での発現用に最適化された合成ヒトパピローマウイルス遺伝子 | |
| ES2398492T3 (es) | Proteínas de fusión que comprenden los antígenos de rechazo tumoral NY-ESO-1 y LAGE-1 | |
| JP2020510426A5 (enExample) | ||
| JP2003530088A5 (enExample) | ||
| CN1921882A (zh) | 同种异基因肿瘤治疗剂 | |
| CN115427071A (zh) | 包含ltb和病原性抗原的组合物及其用途 | |
| RU2006132340A (ru) | Слитые белки карциноэмбрионального антигена | |
| TWI415623B (zh) | 使用小泛素相關融合蛋白表現系統製備類病毒粒子的方法 | |
| CN101096680A (zh) | 一种dna疫苗真核表达载体及其在制备基因疫苗中的应用 | |
| CA2532460A1 (en) | Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof | |
| JP2006501166A5 (enExample) | ||
| CN120324597A (zh) | 编码肿瘤抗原表位的mRNA疫苗及其制备方法和用途 | |
| JP2007511534A5 (enExample) | ||
| CN105801704B (zh) | 一种具有抗宫颈癌细胞活性的重组疫苗构建方法及应用 | |
| TWI259206B (en) | A DNA vaccine containing a tumor associated gene and a cytokine gene and the method producing thereof |